Literature DB >> 17077113

An evaluation of optometrists' ability to correctly identify and manage patients with ocular disease in the accident and emergency department of an eye hospital.

Scott Hau1, Daniel Ehrlich, Katy Binstead, Seema Verma.   

Abstract

AIM: To assess optometrists' ability to correctly identify and manage patients with different ocular conditions seen in the accident and emergency (A&E) department of an eye hospital.
METHODS: Randomly selected patients presenting to the A&E department were initially examined by one of two senior optometrists and a consultant ophthalmologist. A diagnosis and a management plan were made for each patient by the optometrist and by the consultant, who was blinded to the optometrists' plan. Agreement was assessed between optometrist and consultant ophthalmologist for primary and secondary diagnoses, management plan and whether patients could be seen by an optometrist only. Weighted kappa (kappa) statistics was used to assess the level of agreement in management between the two groups.
RESULTS: A total of 150 patients were assessed. The agreement in primary diagnosis and management outcome between the two groups were 89.3% (95% CI 83.2% to 93.8%) and 79.3% (95% CI 84.8% to 94.8%), respectively. A high level of agreement in management outcome was found (kappa = 0.82). No sight-threatening conditions were misdiagnosed by the optometrist.
CONCLUSIONS: There was good agreement in both the diagnosis and management plan between optometrists and the ophthalmologist. This study has shown that optometrists can potentially work safely in an A&E department of a busy eye hospital.

Entities:  

Mesh:

Year:  2006        PMID: 17077113      PMCID: PMC1994753          DOI: 10.1136/bjo.2006.105593

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  An optometrist's role of co-management in a hospital glaucoma clinic.

Authors:  M J Banes; L E Culham; J G Crowston; C Bunce; P T Khaw
Journal:  Ophthalmic Physiol Opt       Date:  2000-09       Impact factor: 3.117

2.  General practice referral letters to a regional ophthalmic accident and emergency department.

Authors:  S Kheterpal; M E Perry; P J McDonnell
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

3.  An extended role for the hospital optometrist.

Authors:  J Oster; L E Culham; R Daniel
Journal:  Ophthalmic Physiol Opt       Date:  1999-07       Impact factor: 3.117

4.  An audit of the ophthalmic division of the accident and emergency department of the Royal Victoria Eye and Ear Hospital, Dublin.

Authors:  S Fenton; E Jackson; M Fenton
Journal:  Ir Med J       Date:  2001-10

5.  Function of an ophthalmic "accident and emergency" department: results of a six month survey.

Authors:  N P Jones; J M Hayward; P T Khaw; C M Claoué; A R Elkington
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

6.  Shared care for glaucoma.

Authors:  R Hitchings
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

7.  The Bristol shared care glaucoma study: outcome at follow up at 2 years.

Authors:  S F Gray; P G Spry; S T Brookes; T J Peters; I C Spencer; I A Baker; J M Sparrow; D L Easty
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

  7 in total
  8 in total

1.  The urgent need to develop emergency EYE care in the UK: the way forward?

Authors:  J C Buchan; B Barnes; A Cassels-Brown; B Y Chang; J Harcourt; R F Pilling; D Shickle; A F Spencer; S A Vernon; C MacEwen
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

Review 2.  Urgent Eye Care in the UK Increased Demand and Challenges for the Future.

Authors:  Thomas Siempis
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

3.  Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial.

Authors:  Barnaby C Reeves; Lauren J Scott; Jodi Taylor; Simon P Harding; Tunde Peto; Alyson Muldrew; Ruth E Hogg; Sarah Wordsworth; Nicola Mills; Dermot O'Reilly; Chris A Rogers; Usha Chakravarthy
Journal:  BMJ Open       Date:  2016-07-08       Impact factor: 2.692

4.  Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial.

Authors:  M Violato; H Dakin; U Chakravarthy; B C Reeves; T Peto; R E Hogg; S P Harding; L J Scott; J Taylor; H Cappel-Porter; N Mills; D O'Reilly; C A Rogers; S Wordsworth
Journal:  BMJ Open       Date:  2016-10-24       Impact factor: 2.692

5.  Collaborative care of non-urgent macular disease: a study of inter-optometric referrals.

Authors:  Angelica Ly; Lisa Nivison-Smith; Michael P Hennessy; Michael Kalloniatis
Journal:  Ophthalmic Physiol Opt       Date:  2016-11       Impact factor: 3.117

6.  Prevalence of visual impairment due to refractive error among children and adolescents in Ethiopia: A systematic review and meta-analysis.

Authors:  Daniel Atlaw; Zerihun Shiferaw; Biniyam Sahiledengele; Sisay Degno; Ayele Mamo; Demisu Zenbaba; Habtamu Gezahegn; Fikreab Desta; Wogene Negash; Tesfaye Assefa; Mujib Abdela; Abbul Hasano; Gashaw Walle; Chala Kene; Degefa Gomora; Vijay Kumar Chattu
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

7.  The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease.

Authors:  J Taylor; L J Scott; C A Rogers; A Muldrew; D O'Reilly; S Wordsworth; N Mills; R Hogg; M Violato; S P Harding; T Peto; D Townsend; U Chakravarthy; B C Reeves
Journal:  Eye (Lond)       Date:  2015-10-09       Impact factor: 3.775

8.  Systematic review of the appropriateness of eye care delivery in eye care practice.

Authors:  Kam Chun Ho; Fiona Stapleton; Louise Wiles; Peter Hibbert; Sally Alkhawajah; Andrew White; Isabelle Jalbert
Journal:  BMC Health Serv Res       Date:  2019-09-06       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.